Berendsen, Tim A
Bruinsma, Bote G
Puts, Catheleyne F
Saeidi, Nima
Usta, O Berk
Uygun, Basak E
Izamis, Maria-Louisa
Toner, Mehmet
Yarmush, Martin L
Uygun, Korkut
Article History
Received: 13 December 2012
Accepted: 27 February 2014
First Online: 29 June 2014
Competing interests
: M.L.I., B.E.U., K.U. and M.L.Y. are inventors on a pending international patent application that involves some of the perfusion technology used in this work (WO/2011/002926); T.A.B., M.L.I., B.E.U., M.L.Y. and K.U. are inventors on a pending international patent application that describes the supercooling protocol employed in this work (WO/2011/35223); and B.G.B., M.L.I. and K.U. have a provisional patent application related to this work that describes scale-up of the perfusion protocol to human livers. K.U. has a financial interest in Organ Solutions LLC, a company focused on developing organ preservation technology. K.U.'s interests are managed by the Massachusetts General Hospital and Partners HealthCare in accordance with their conflict-of-interest policies.